J3M-MC-JZQH

By Medable, Inc. on AppTrack Ninja.

A Phase 3, Multicenter, Double-Blind, Placebo-controlled Study Assessing the Efficacy and Safety of Olomorasib in Combination with Standard of Care Immunotherapy in Participants with Resected or Unresectable KRAS G12C-Mutant, Non-Small Cell Lung Cancer - SUNRAY-02. This app is specifically intended for participants in the J3M-MC-JZQH study only.

Categories: Health & Fitness

App Store rankings, screenshots, estimates and similar apps for J3M-MC-JZQH.